FastForm is a dynamic life science company headquartered in Waterford, Ireland. Our mission is to deliver our advanced medical devices worldwide to improve the healing experiences of patients and empower physicians with fast, convenient, cost-effective treatment solutions.
The company is focused on the development and commercialization of its advanced range of multifunctional orthoses for orthopaedic and wound-care markets. FastForm brings industry leading clinical and patient benefits to physicians worldwide, and attractive profit margins for the company and its partners.
The company has mostly focused its commercial efforts in the US market due to the receptiveness there for innovative medical devices and the favorable reimbursement rates. Since 2015 we have been selling our upper extremity (UE) orthopaedic product range to clinics and hospitals through a US distributor. We now wish to expand sales of our current UE range in the US in states that are currently underrepresented and international markets particularly the Middle East and Japan. We have also developed an advanced Lower extremity product range for fractures, tissue trauma and post op-indications, which will be launched later this year.
Exceeding the market opportunity for Lower limb fractures, we have identified a large market opportunity for a better way to treat patients with Diabetic Foot Ulcers (DFUs). We have developed an advanced product range that we believe will revolutionize the treatment and offloading of Diabetic Foot Ulcers, an indication that contributes to over 100,000 foot amputations alone in the US each year. To grow our business we are interested in partnering with distributors that have a strong presence in the orthopaedic and wound care market segments.
Delivering our advanced medical devices worldwide to improve the healing experiences of patients and empower physicians with fast, convenient, cost-effective treatment solutions. Advanced multifunctional orthosis range with significant reimbursement potential and attractive profit margins for orthopaedic fractures, musculoskeletal injuries, and wound care. Physicians can reduce costs with a time saving yet highly effective treatment modality to deliver customised immobilisation and Total Contact offloading, the gold standard for Diabetic Foot Ulcers globally.
From minimum inventory levels to positioning our salespeople for recurring orders and approved PDAC reimbursement, our aim is to help our distribution partners gain maximum benefit from working with us.
We plan to offer a full upper and lower limb range of products to the market. Our technology is designed to be durable, strong and for loadbearing products, unlike other comparable technologies sold in the US.
Healthcare; Life Sciences; Med Devices; Medical
USA, international markets